Literature DB >> 18662507

The SLICC inception cohort for atherosclerosis.

Murray B Urowitz1, Dafna D Gladman.   

Abstract

The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) is a group of rheumatologists and methodologists from 27 international centers who have a particular interest and expertise in systemic lupus erythematosus. Initially, its efforts focused on development and validation of disease activity and damage indices. In 2000, the SLICC Registry for Atherosclerosis was established to determine the incidence, prevalence, nature, and risk factors of atherosclerotic coronary artery disease in systemic lupus erythematosus. Risk factors for coronary artery disease at presentation to the cohort were reported, as well as their accumulation over the first few years. Development of the metabolic syndrome was also described. Among the first 1078 patients who entered the cohort, 61 vascular events have occurred in 47 patients who were older at diagnosis and more likely male and hypertensive than were the patients without vascular events. Additional studies using this cohort are ongoing.

Entities:  

Mesh:

Year:  2008        PMID: 18662507     DOI: 10.1007/s11926-008-0045-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  24 in total

1.  The Systemic Lupus International Collaborating Clinics Group--origins and outcomes.

Authors:  D A Isenberg; D Gladman
Journal:  Lupus       Date:  2001       Impact factor: 2.911

2.  Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

3.  Race/ethnicity and cancer occurrence in systemic lupus erythematosus.

Authors:  S Bernatsky; J F Boivin; L Joseph; S Manzi; E Ginzler; M Urowitz; D Gladman; P Fortin; C Gordon; S Barr; S Edworthy; S C Bae; M Petri; J Sibley; D Isenberg; A Rahman; K Steinsson; C Aranow; M A Dooley; G S Alarcon; J Hanly; G Sturfelt; O Nived; J Pope; S Ensworth; R Rajan; H El-Gabalawy; T McCarthy; Y St Pierre; A Clarke; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  2005-10-15

4.  Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; C Bombardier; D Isenberg; K Kalunian; M H Liang; P Maddison; O Nived
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

Review 5.  Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group.

Authors:  D Gladman; M Urowitz; P Fortin; D Isenberg; C Goldsmith; C Gordon; M Petri
Journal:  J Rheumatol       Date:  1996-11       Impact factor: 4.666

6.  Criteria for assessing disease activity in systemic lupus erythematosus.

Authors:  D Isenberg; P Bacon; C Bombardier; D Gladman; C H Goldsmith; K Kalunian; M Liang; P Maddison; O Nived; M Richter
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

7.  Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.

Authors:  M B Urowitz; D Gladman; D Ibañez; P Fortin; J Sanchez-Guerrero; S Bae; A Clarke; S Bernatsky; C Gordon; J Hanly; D Wallace; D Isenberg; E Ginzler; J Merrill; G Alarcon; K Steinsson; M Petri; M A Dooley; I Bruce; S Manzi; M Khamashta; R Ramsey-Goldman; A Zoma; G Sturfelt; O Nived; P Maddison; J Font; R van Vollenhoven; C Aranow; K Kalunian; T Stoll; J Buyon
Journal:  Lupus       Date:  2007       Impact factor: 2.911

8.  Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; C Bombardier; D Isenberg; K Kalunian; M H Liang; P Maddison; O Nived
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

View more
  3 in total

1.  Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico.

Authors:  América G Uribe; Juanita Romero-Díaz; Mandar Apte; Mónica Fernández; Paula I Burgos; John D Reveille; Jorge Sánchez-Guerrero; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-08-28       Impact factor: 7.580

2.  Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.

Authors:  Parasar Ghosh; Amresh Kumar; Sudeep Kumar; Amita Aggarwal; Nakul Sinha; Ramnath Misra
Journal:  Clin Rheumatol       Date:  2009-07-19       Impact factor: 2.980

3.  Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Murray B Urowitz; John G Hanly; Caroline Gordon; Michelle A Petri; Ellen M Ginzler; Daniel J Wallace; Sang-Cheol Bae; Juanita Romero-Diaz; Mary Anne Dooley; Christine A Peschken; David A Isenberg; Anisur Rahman; Susan Manzi; Søren Jacobsen; S Sam Lim; Ronald van Vollenhoven; Ola Nived; Diane L Kamen; Cynthia Aranow; Guillermo Ruiz-Irastorza; Jorge Sánchez-Guerrero; Dafna D Gladman; Paul R Fortin; Graciela S Alarcón; Joan T Merrill; Kenneth C Kalunian; Manuel Ramos-Casals; Kristjan Steinsson; Asad Zoma; Anca Askanase; Munther A Khamashta; Ian Bruce; Murat Inanc; Ann E Clarke
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-10-12       Impact factor: 5.178

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.